These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 13765381)

  • 41. [Importance of a new synthetic vasodilator, Caa 40, in the treatment of chronic ulcers of the lower extremities].
    THIERS H; COLOMB D; FAYOLLE J; ARCADIO F; NOVE JOSSERAND
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():217-21. PubMed ID: 13837804
    [No Abstract]   [Full Text] [Related]  

  • 42. [On a new method of therapy of peripheral and cerebral circulatory disorders with 3-(methyioxyethylamino)-2-hydroxypropyltheophylline-beta-pyridinecarboxylic acid (complamin)].
    THIESEN J; FISCHER T
    Medizinische; 1959 Aug; 31-32():1427-32. PubMed ID: 13837851
    [No Abstract]   [Full Text] [Related]  

  • 43. [Value of high doses of amygdalic ester of 3,5,5-trimethylcyclohexanol (cyclospasmol) in the treatment of peripheral vascular disorders].
    MATHIEU L; PERNOT C; METZ J; STREIFF F
    Rev Med Nancy; 1959 Mar; 84():255-67. PubMed ID: 13646365
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative efficacy of some peripheral vasodilators by a method utilizing an albumin labeled with iodine-131].
    GERAUD J; BRU A; BES A; RASCOL A; d' ANDRIESENS
    Presse Med (1893); 1961 Apr; 69():807-9. PubMed ID: 13704532
    [No Abstract]   [Full Text] [Related]  

  • 45. [Demonstration on a trial treatment with Euclidan injected by the intra-arterial route of severe ischemic conditions of the lower limbs].
    BRUN F; PLAUCHU G; PERRIN A
    Lyon Med; 1962 Jun; 94():1413-25. PubMed ID: 13873962
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cyclospasmol (mandelic acid ester of 3,5,5-trimethylcyclohexanol) in therapy of skin diseases].
    DOORNINK FJ
    Geneeskd Gids; 1953 Jun; 31(12):247-51. PubMed ID: 13083900
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of peripheral vascular diseases with tocopheral and with eupaverin].
    FERABOLI PC
    Gazz Med Ital; 1952 Nov; 111(11):285-8. PubMed ID: 13043798
    [No Abstract]   [Full Text] [Related]  

  • 48. [Action of phenetamine on peripheral arterial disorders].
    CLOETENS W; DERNIER J; DE MEY D
    Brux Med; 1960 Nov; 40():1647-72. PubMed ID: 13694132
    [No Abstract]   [Full Text] [Related]  

  • 49. Isoxsuprine for the treatment of dysmenorrhea. A double-blind study of 143 subjects.
    RUBIN A
    Obstet Gynecol; 1962 Jan; 19():9-10. PubMed ID: 14494890
    [No Abstract]   [Full Text] [Related]  

  • 50. Prolongation of the bleeding time by means of cyclospasmol.
    FUNCKE AB; VAN ESVELD CL
    Arch Int Pharmacodyn Ther; 1955 Nov; 104(1):83-9. PubMed ID: 13283646
    [No Abstract]   [Full Text] [Related]  

  • 51. The case against vasodilator drugs in occlusive vascular disease of the legs.
    GILLESPIE JA
    Lancet; 1959 Dec; 2(7110):995-7. PubMed ID: 13850087
    [No Abstract]   [Full Text] [Related]  

  • 52. [Studies on spasmolytics. II. Effect of structural changes in nitrogen-free esters with spasmolytic action; phenylacetic acid and dyphenylacetic acid ester; various derivatives 3,3,5-trimethycyclohexyl-amygdalate (cyclospasmol)].
    FUNCKE AB; ERNSTING MJ; GOOTJES J; REKKER RF; NAUTA WT
    Arzneimittelforschung; 1954 Aug; 4(8):492-4. PubMed ID: 13198750
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy of peripheral arteriopathies with the combination of a vasodilator and a vasotonic].
    SAVIO O
    Minerva Med; 1960 May; 51():1962-6. PubMed ID: 14442064
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the use of a new spasmolytic factor in the therapy of peripheral arteriopathies].
    DE RUBERTIS C; PIERANGELI A; MORGANTI I
    Minerva Chir; 1960 Jun; 15():625-31. PubMed ID: 13815007
    [No Abstract]   [Full Text] [Related]  

  • 55. [Blocardren, phenoxybenzamine hydrochloride. A vasodilator with peripheral action].
    BLOCH J; VIDEBAEK A
    Ugeskr Laeger; 1959 Sep; 121():1443-6. PubMed ID: 13801506
    [No Abstract]   [Full Text] [Related]  

  • 56. Vasodilator drugs against experimental peripheral gangrene; a method of testing the effect of vasodilator drugs on constricted peripheral vessels.
    LUND F
    Acta Physiol Scand Suppl; 1951; 82():1-141. PubMed ID: 14868532
    [No Abstract]   [Full Text] [Related]  

  • 57. Methods used to evaluate vasodilator drugs.
    STALLWORTH JM; LEE WH; JEFFORDS JV
    Angiology; 1958 Dec; 9(6):366-77. PubMed ID: 13606425
    [No Abstract]   [Full Text] [Related]  

  • 58. Experiences with regitin, a new vasodilator compound.
    SELVAAG O; RIISER S
    Acta Med Scand; 1953; 146(3):209-15. PubMed ID: 13091731
    [No Abstract]   [Full Text] [Related]  

  • 59. Intra-arterial vasodilator agents in the treatment of advanced occlusive arterial disease of the extremities; a preliminary report of a new vasodilator drug, 27 MI.
    ROSE OA; EBEL A
    J Am Geriatr Soc; 1956 Feb; 4(2):142-50. PubMed ID: 13295017
    [No Abstract]   [Full Text] [Related]  

  • 60. Vasodilator drugs in peripheral vascular disease.
    Coffman JD
    Am J Hosp Pharm; 1975 Dec; 32(12):1276-81. PubMed ID: 1108646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.